Big Move For Replimune Group, Inc.
Mon, Oct 20, 2025 at 07:34 PM
Replimune Group, Inc. (REPL:NASDAQ) rocketted at $8.95, representing a gain of 98.8%. On Mon, Oct 20, 2025, REPL:NASDAQ hit a New 2-Week High of $8.95. The stock appeared on our News Catalysts scanner on Mon, Oct 20, 2025 at 05:07 PM in the 'MISCELLANEOUS' category. From Mon, Oct 06, 2025, the stock recorded 40.00% Up Days and 27.27% Green Days
The stock spiked on Mon, Jul 21, 2025 at $13.24 with a volume of 4M+.
About Replimune Group, Inc. (REPL:NASDAQ)
Replimune Group Inc is a clinical-stage biotechnology company. Its use proprietary Immulytic platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The company's pipeline products include RP1, RP2, and RP3.
Top 10 Gainers:
- Movella Holdings Inc. (MVLA:NASDAQ), 325%
- GSI Technology, Inc. (GSIT:NASDAQ), 155.32%
- Beyond Meat, Inc. (BYND:NASDAQ), 127.7%
- Replimune Group, Inc. (REPL:NASDAQ), 98.78%
- Alto Neuroscience, Inc. (ANRO:NYSE), 80.92%
- Kuke Music Holding Limited (KUKE:NYSE), 49.06%
- 9F Inc. (JFU:NASDAQ), 43.47%
- Kaixin Holdings (KXIN:NASDAQ), 40%
- American Battery Technology Company (ABAT:NASDAQ), 38.56%
- Rani Therapeutics Holdings, Inc. (RANI:NASDAQ), 37.2%